D2G Oncology is a precision-oncology company based in Mountain View, California, reported to have been founded in 2018 by Ian Winters. Public company descriptions characterize its work as applying quantitative and multiplexed functional cancer genomics to relate drugs to genotypes in order to advance precision cancer therapeutics. - View it on GitHub